Alterations of the neutrophil–lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients

Clinical Respiratory Journal

Volumn 11, Issue 3, 2017, Pages 311-317

  Taylan, Mahsuk ^a   Demir, Melike ^a   Kaya, Halide ^a   Selimoglu Sen, Hadice ^a   Abakay, Ozlem ^a   Carkanat, Ali İhsan ^a   Abakay, Abdurrrahman ^a   Tanrikulu, Abdullah Cetin ^a   Sezgi, Cengizhan ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

acute exacerbation; chronic obstructive pulmonary disease; complete blood count; inflammation; marker; neutrophil lymphocyte ratio

Indexed keywords

C REACTIVE PROTEIN; BIOLOGICAL MARKER;

AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD CELL COUNT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FORCED VITAL CAPACITY; GENERAL ASPECTS OF DISEASE; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STABLE DISEASE; THROMBOCYTE COUNT; BLOOD; COMPARATIVE STUDY; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; IMMUNOLOGY; INFLAMMATION; LUNG FUNCTION TEST; LYMPHOCYTE; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; BIOMARKERS; BLOOD CELL COUNT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; INFLAMMATION; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84938810958     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12336     Document Type: Article

References (28)

1. Global Strategy for the Diagnosis. Management and Prevention of COPD, Global Initiative for Chronic Obstructive Pulmonary Disease. (Updated 2015) http://www.goldcopd.org/uploads/users/files/GOLD_Report_2015_Apr2.pdf.
2. Wedzicha JA, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care. 2003;48(12): 1204–13.
3. Schols AM, Buurman WA, Staalvan den Brekel AJ, Dentener MA, Wouters EF. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax. 1996;51(8): 819–24.
4. Carreiro A, Santos J, Rodrigues F. Impact of comorbidities in pulmonary rehabilitation outcomes in patients with chronic obstructive pulmonary disease. Rev Port Pneumol. 2013;19(3): 106–13.
5. Jones PW, Agusti AG. Out comes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4): 822–32.
6. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5): 1434–40.
7. Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2): 416–69.
8. Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA. 2013;309(22): 2353–61.
9. Torun S, Tunc BD, Suvak B, Yildiz H, Tas A, Sayilir A, Ozderin YO, Beyazit Y, Kayacetin E. Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity. Clin Res Hepatol Gastroenterol. 2012;36(5): 491–7.
10. Azab B, Jaglall N, Atallah JP, Lamet A, Raja-Surya V, Farah B, Lesser M, Widmann WD. Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology. 2011;11(4): 445–52.
11. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol. 2008;102(6): 653–7.
12. Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1): 5–14.
13. Gunay E, Sarınç Ulaşlı S, Akar O, Ahsen A, Gunay S, Koyuncu T, Unlü M. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study. Inflammation. 2014;37(2): 374–80.
14. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6): 932–46.
15. Hurst JR, Wedzicha JA. Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation. Postgrad Med J. 2004;80(947): 497–505.
16. Thorleifsson SJ, Margretardottir OB, Gudmundsson G, Olafsson I, Benediktsdottir B, Janson C, Buist AS, Gislason T. Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland. Respir Med. 2009;103(10): 1548–53.
17. Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med. 2008;19(2): 104–8.
18. Karadeniz G, Polat G, Senol G, Buyuksirin M. C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations. Inflammation. 2013;36(4): 948–53.
19. Tofan F, Rahimi-Rad MH, Rasmi Y, Rahimirad S. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease. Pneumologia. 2012;61(3): 160–2.
20. Patel AR, Hurst JR, Wedzicha JA. The potential value of biomarkers in diagnosis and staging of COPD and exacerbations. Semin Respir Crit Care Med. 2010;31(3): 267–75.
21. Pazarli AC, Koseoglu HI, Doruk S, Sahin S, Etikan I, Celikel S, Berktas B. Procalcitonin: is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation. J Res Med Sci. 2012;17(11): 1047–51.
22. Kirdar S, Serter M, Ceylan E, Sener AG, Kavak T, Karadağ F. Adiponectin as a biomarker of systemic inflammatory response in smoker patients with stable and exacerbation phases of chronic obstructive pulmonary disease. Scand J Clin Lab Invest. 2009;69(2): 219–24.
23. Mohan A, Prasad D, Sharma A, Arora S, Guleria R, Sharma SK, Pandey RM. Delayed resolution of inflammatory response compared with clinical recovery in patients with acute exacerbations of chronic obstructive pulmonary disease. Respirology. 2012;17(7): 1080–5.
24. Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V, Incalzi RA. C-reactive protein and erythrocyte sedimentation rate as inflammation markers in elderly patients with stable chronic obstructive pulmonary disease. Arch Gerontol Geriatr. 2011;53(2): 190–5.
25. Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10): 1065–72.
26. Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE. Neutrophil to lymphocyte ratio: A new marker for predicting steatohepatitis and fi-brosis in patients with nonalcoholic fatty liver disease. Liver Int. 2012;32(2): 297–302.
27. de Jager CP, Wever PC, Gemen EF, Kusters R, van Gageldonk-Lafeber AB, van der Poll T, Laheij RJ. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One. 2012;7: e46561.
28. Markar SR, Karthikesalingam A, Falzon A, Kan Y. The diagnostic value of neutrophil: lymphocyte ratio in adults with suspected acute appendicitis. Acta Chir Belg. 2010;110(5): 543–7.